Șeclăman EP - Search Results

1

The role of Anti-VEGF agents in treatment of neovascular glaucoma.

Palfi Salavat MC, Șeclăman EP, Barac R, Ungureanu E, Iorgu G, Artamonov A, Leuștean L, Borugă MV. Palfi Salavat MC, et al. Among authors: seclaman ep. Rom J Ophthalmol. 2022 Jul-Sep;66(3):209-213. doi: 10.22336/rjo.2022.41. Rom J Ophthalmol. 2022. PMID: 36349171 Free PMC article. Review.

2

In vitro and in ovo experimental study of two anti-VEGF agents used in ophthalmology.

Palfi MC, Muşat O, Şeclăman EP, Munteanu M, Milcu AI, Iordache A, Dolghi A, Istrate SL, Barac IR, Borugă VM. Palfi MC, et al. Among authors: seclaman ep. Rom J Morphol Embryol. 2021 Jul-Sep;62(3):801-806. doi: 10.47162/RJME.62.3.18. Rom J Morphol Embryol. 2021. PMID: 35263409 Free PMC article.

3

Aflibercept Versus Bevacizumab as First-Line Therapy in Age-Related Macular Degeneration.

Palfi Salavat MC, Șeclăman EP, Mușat AA, Borugă M, Patoni C, Popescu MN, Teodorescu OE, Mușat O, Popescu Patoni SI. Palfi Salavat MC, et al. Among authors: seclaman ep. Curr Health Sci J. 2023 Oct-Dec;49(4):503-509. doi: 10.12865/CHSJ.49.04.4. Epub 2023 Dec 29. Curr Health Sci J. 2023. PMID: 38559826 Free PMC article.

4

VEGF-A/HGF induce Prox-1 expression in the chick embryo chorioallantoic membrane lymphatic vasculature.

Cimpean AM, Seclaman E, Ceauşu R, Gaje P, Feflea S, Anghel A, Raica M, Ribatti D. Cimpean AM, et al. Clin Exp Med. 2010 Sep;10(3):169-72. doi: 10.1007/s10238-009-0085-6. Epub 2009 Dec 24. Clin Exp Med. 2010. PMID: 20033752

5

Safety of vascular endothelial and hepatocyte growth factor gene therapy in patients with critical limb ischemia.

Anghel A, Taranu G, Seclaman E, Rata A, Tamas L, Moldovan H, Ursoniu S, Samoila C, Ionac M, Popa-Wagner A. Anghel A, et al. Curr Neurovasc Res. 2011 Aug 1;8(3):183-9. doi: 10.2174/156720211796558050. Curr Neurovasc Res. 2011. PMID: 21675956 Clinical Trial.

6

Clinical improvement after treatment with VEGF(165) in patients with severe chronic lower limb ischaemia.

Anghel A, Mut-Vitcu B, Savu L, Marian C, Seclaman E, Iman R, Neghina AM, Dragulescu SI. Anghel A, et al. Genomic Med. 2007;1(1-2):47-55. doi: 10.1007/s11568-007-9006-5. Epub 2007 May 25. Genomic Med. 2007. PMID: 18923928 Free PMC article.

7

Molecular profiling of ADAM12 gene in breast cancers.

Nariţa D, Anghel A, Seclaman E, Ilina R, Cireap N, Ursoniu S. Nariţa D, et al. Rom J Morphol Embryol. 2010;51(4):669-76. Rom J Morphol Embryol. 2010. PMID: 21103624 Free article.

8

Expression of CCL18 and interleukin-6 in the plasma of breast cancer patients as compared with benign tumor patients and healthy controls.

Nariţa D, Seclaman E, Ursoniu S, Ilina R, Cireap N, Anghel A. Nariţa D, et al. Rom J Morphol Embryol. 2011;52(4):1261-7. Rom J Morphol Embryol. 2011. PMID: 22203932 Free article.

9

Uncovering the Roles of MicroRNAs in Major Depressive Disorder: From Candidate Diagnostic Biomarkers to Treatment Response Indicators.

Homorogan C, Nitusca D, Seclaman E, Enatescu V, Marian C. Homorogan C, et al. Life (Basel). 2021 Oct 11;11(10):1073. doi: 10.3390/life11101073. Life (Basel). 2021. PMID: 34685444 Free PMC article. Review.

10

Distribution of NDM1 Carbapenemase-Producing Proteeae Strains on High-Risk Hospital Wards.

Rus M, Licker M, Musuroi C, Seclaman E, Muntean D, Cirlea N, Tamas A, Vulpie S, Horhat FG, Baditoiu L. Rus M, et al. Infect Drug Resist. 2020 Dec 31;13:4751-4761. doi: 10.2147/IDR.S280977. eCollection 2020. Infect Drug Resist. 2020. PMID: 33408490 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page